One hour access (shock baseline)

Tags: Behavior · Cocaine

Project: p50_paul_meyer_2020

2 loci · 2 genes with independent associations · 2 total associated genes

Significant Loci

# Chr Start pos End pos # assoc genes # joint models Best TWAS P Best GWAS P Cond GWAS P Joint genes
1 chr1 79485178 80785451 1 1 3.99e-08 2.65e-02 5.37e-01 Zfp575
2 chr8 33211184 34601262 1 1 7.66e-12 2.68e-01 1.38e-14 Ddx25

Pleiotropic Associations

Trait Chi2 ratio # genes+ # genes++ % genes++ Corr Corr P Genes
BMI with tail 1.62 1 0 0 0 1e+00 Ddx25
BMI without tail 3.34 2 0 0 0 1e+00 Ddx25 Zfp575
Left kidney weight 2.5 1 0 0 0 1e+00 Zfp575
Right kidney weight 2.13 2 0 0 0 1e+00 Ddx25 Zfp575
Tail length 4.24 2 0 0 0 1e+00 Ddx25 Zfp575
Length without tail 4.72 2 0 0 0 1e+00 Ddx25 Zfp575
Parametrial fat weight 2.77 2 0 0 0 1e+00 Ddx25 Zfp575
Patch foraging total patch changes 24 sec 4.53 1 0 0 0 1e+00 Zfp575
Patch foraging water rate 6 sec 4.97 1 0 0 0 1e+00 Zfp575
Locomotor activity 4.49 1 0 0 0 1e+00 Ddx25
Locomotor testing distance 4.75 1 0 0 0 1e+00 Ddx25
Locomotor testing rearing 3.33 1 0 0 0 1e+00 Ddx25
Reaction time number correct 4.8 1 0 0 0 1e+00 Zfp575
Reaction time mean minus median AUC 3.91 1 0 0 0 1e+00 Ddx25
Reaction time trials correct on left 4.8 1 0 0 0 1e+00 Zfp575
Reaction time trials on left 4.9 1 0 0 0 1e+00 Zfp575
Reaction time mean 4.79 1 0 0 0 1e+00 Ddx25
Reaction time trials completed 4.9 1 0 0 0 1e+00 Zfp575
Reaction time trials AUC 4.63 1 0 0 0 1e+00 Zfp575
Social responses 4.22 1 0 0 0 1e+00 Zfp575
Conditioned reinforcement - actives 5.59 1 0 0 0 1e+00 Zfp575
Conditioned reinforcement - inactives 9.88 2 0 0 0 1e+00 Ddx25 Zfp575
Conditioned locomotion 5.33 1 0 0 0 1e+00 Zfp575
Intermittent access intake day 1-15 change 78.98 1 1 50 0 1e+00 Ddx25
Intermittent access intake escalation 41.26 1 1 50 0 1e+00 Ddx25
Intermittent access intake escalation 2 33.1 1 1 50 0 1e+00 Ddx25
Intermitt. access day 1 inactive lever presses 25.7 1 1 50 0 1e+00 Ddx25
Intermitt. access day 15 inactive lever presses 40.88 1 1 50 0 1e+00 Ddx25
Intermitt. access escalation Index 14.59 1 0 0 0 1e+00 Ddx25
Intermittent access day 15 total infusions 29.23 2 1 50 0 1e+00 Ddx25 Zfp575
Intermittent access terminal intake (last 3 days) 27.22 2 1 50 0 1e+00 Ddx25 Zfp575
Intermittent access total infusions 19.23 2 1 50 0 1e+00 Ddx25 Zfp575
Intermittent access day 1 locomotion 5.4 1 0 0 0 1e+00 Zfp575
Intermittent access total locomotion 11.21 1 0 0 0 1e+00 Zfp575
Intermittent access standard deviation 12.4 2 0 0 0 1e+00 Ddx25 Zfp575
Cocaine induced anxiety 12.68 1 0 0 0 1e+00 Ddx25
Baseline Anxiety 5.61 1 0 0 0 1e+00 Ddx25
Lifetime Intake 26.35 2 1 50 0 1e+00 Ddx25 Zfp575
Incentive Sensitization - Responses 20.69 2 0 0 0 1e+00 Ddx25 Zfp575
Incentive Sensitization - Breakpoint 24.16 2 1 50 0 1e+00 Ddx25 Zfp575
Progressive ratio test 1 active lever presses 8.93 1 0 0 0 1e+00 Ddx25
Progressive ratio test 1 breakpoint 6.86 1 0 0 0 1e+00 Ddx25
Progressive ratio test 1 inactive lever presses 14.06 1 0 0 0 1e+00 Ddx25
Progressive ratio test 2 active lever presses 11.94 2 0 0 0 1e+00 Ddx25 Zfp575
Progressive ratio test 2 breakpoint 14.19 2 0 0 0 1e+00 Ddx25 Zfp575
Progressive ratio test 2 inactive lever presses 22.03 2 1 50 0 1e+00 Ddx25 Zfp575
Total sessions with >9 infusions 15.26 2 0 0 0 1e+00 Ddx25 Zfp575
Short access day 1 total inactive lever presses 26.73 1 1 50 0 1e+00 Zfp575
Short access day 1 total infusions 27.87 2 1 50 0 1e+00 Ddx25 Zfp575
Short access day 10 total infusions 32.96 1 1 50 0 1e+00 Ddx25
Short access total infusions 54.56 1 1 50 0 1e+00 Ddx25
Short access day 10 total locomotion 11.38 1 0 0 0 1e+00 Ddx25
Compulsive drug intake 14.12 1 0 0 0 1e+00 Zfp575
One hour access (0.3 mA shock) 58.39 2 2 100 0 1e+00 Ddx25 Zfp575
Number of responses in last shaping day 22.04 2 1 50 0 1e+00 Ddx25 Zfp575
Bone: cortical area 7.52 1 0 0 0 1e+00 Ddx25
Bone: cortical thickness 4.39 1 0 0 0 1e+00 Ddx25
Bone: cortical thickness 5.77 1 0 0 0 1e+00 Ddx25
Bone: final force 5.29 1 0 0 0 1e+00 Ddx25
Bone: final moment 4.65 1 0 0 0 1e+00 Ddx25
Bone: maximum force 6.75 1 0 0 0 1e+00 Ddx25
Bone: maximum moment 5.84 1 0 0 0 1e+00 Ddx25
Bone: minimum diameter 3.6 1 0 0 0 1e+00 Ddx25
Bone: periosteal estimation 3.75 1 0 0 0 1e+00 Ddx25
Bone: stiffness 4.98 1 0 0 0 1e+00 Ddx25
Bone: trabecular thickness 4.3 1 0 0 0 1e+00 Ddx25
Distance traveled before self-admin 16.37 2 0 0 0 1e+00 Ddx25 Zfp575
Distance traveled after self-admin 10.59 2 0 0 0 1e+00 Ddx25 Zfp575
Delta time in closed arm before/after self-admin 6.42 1 0 0 0 1e+00 Ddx25
Extinction: sum of active levers before priming 20.46 2 0 0 0 1e+00 Ddx25 Zfp575
Active lever presses in extinction session 6 9.2 2 0 0 0 1e+00 Ddx25 Zfp575
Delta distance traveled before/after self-admin 6.76 1 0 0 0 1e+00 Ddx25
Delta ambulatory time before/after self-admin 14.46 1 0 0 0 1e+00 Ddx25
Time in closed arm after self-admin 5 1 0 0 0 1e+00 Zfp575
Time in open arm before self-admin 21.1 1 0 0 0 1e+00 Zfp575
Time to tail flick, vehicle, before self-admin 9.26 1 0 0 0 1e+00 Ddx25
Time to tail flick, vehicle, after self-admin 9 1 0 0 0 1e+00 Zfp575
Time to tail flick, test, before self-admin 8.19 2 0 0 0 1e+00 Ddx25 Zfp575
Ambulatory time before self-admin 18.76 2 1 50 0 1e+00 Ddx25 Zfp575
Ambulatory time after self-admin 5.96 2 0 0 0 1e+00 Ddx25 Zfp575
Total heroin consumption 8.9 1 0 0 0 1e+00 Ddx25
Change in fecal boli incidents, locomotor task 5.67 1 0 0 0 1e+00 Zfp575
Vertical activity count, locomotor time 1 13.25 1 0 0 0 1e+00 Zfp575
Weight adjusted by age 15.78 1 0 0 0 1e+00 Zfp575
Seeking ratio, delayed vs. immediate footshock 10.88 1 0 0 0 1e+00 Zfp575
Locomotion in novel chamber 6.51 1 0 0 0 1e+00 Zfp575
Food seeking constrained by brief footshock 11.04 1 0 0 0 1e+00 Zfp575
Run reversals in cocaine runway, males 8.37 1 0 0 0 1e+00 Ddx25
Latency to leave start box in cocaine runway 5.91 1 0 0 0 1e+00 Ddx25
Latency to leave start box in cocaine runway, M 12.73 2 0 0 0 1e+00 Ddx25 Zfp575
Sr content in liver 7.99 2 0 0 0 1e+00 Ddx25 Zfp575

Associations by panel

Tissue RNA modality # hits % hits/tests Avg chisq
Adipose alternative polyA 0 0 1.12
Adipose alternative TSS 0 0 1.11
Adipose gene expression 1 0 1.13
Adipose isoform ratio 0 0 1.13
Adipose intron excision ratio 0 0 1.07
Adipose mRNA stability 0 0 1.15
BLA alternative polyA 0 0 1.16
BLA alternative TSS 0 0 1.18
BLA gene expression 0 0 1.16
BLA isoform ratio 0 0 1.15
BLA intron excision ratio 0 0 1.11
BLA mRNA stability 0 0 1.2
Brain alternative polyA 0 0 1.16
Brain alternative TSS 0 0 1.11
Brain gene expression 0 0 1.17
Brain isoform ratio 0 0 1.19
Brain intron excision ratio 0 0 1.18
Brain mRNA stability 0 0 1.2
Eye alternative polyA 0 0 1.26
Eye alternative TSS 0 0 1.06
Eye gene expression 0 0 1.2
Eye isoform ratio 0 0 1.18
Eye intron excision ratio 0 0 1.14
Eye mRNA stability 0 0 1.19
IL alternative polyA 0 0 1.17
IL alternative TSS 0 0 1.12
IL gene expression 0 0 1.15
IL isoform ratio 0 0 1.17
IL intron excision ratio 0 0 1.18
IL mRNA stability 0 0 1.3
LHb alternative polyA 0 0 1.11
LHb alternative TSS 0 0 1.26
LHb gene expression 0 0 1.19
LHb isoform ratio 0 0 1.26
LHb intron excision ratio 0 0 1.01
LHb mRNA stability 0 0 1.24
Liver alternative polyA 0 0 1.21
Liver alternative TSS 0 0 1.24
Liver gene expression 0 0 1.13
Liver isoform ratio 0 0 1.18
Liver intron excision ratio 0 0 1.14
Liver mRNA stability 0 0 1.13
NAcc alternative polyA 0 0 1.16
NAcc alternative TSS 0 0 1.13
NAcc gene expression 0 0 1.18
NAcc isoform ratio 0 0 1.15
NAcc intron excision ratio 0 0 1.14
NAcc mRNA stability 0 0 1.18
OFC alternative polyA 0 0 1.23
OFC alternative TSS 0 0 1.11
OFC gene expression 0 0 1.14
OFC isoform ratio 0 0 1.17
OFC intron excision ratio 0 0 1.09
OFC mRNA stability 0 0 1.21
PL alternative polyA 0 0 1.21
PL alternative TSS 0 0 1.13
PL gene expression 0 0 1.15
PL isoform ratio 0 0 1.2
PL intron excision ratio 0 0 1.19
PL mRNA stability 1 0 1.23
pVTA alternative polyA 0 0 1.22
pVTA alternative TSS 0 0 1.24
pVTA gene expression 0 0 1.18
pVTA isoform ratio 0 0 1.23
pVTA intron excision ratio 0 0 1.16
pVTA mRNA stability 0 0 1.27
RMTg alternative polyA 0 0 1.23
RMTg alternative TSS 0 0 0.95
RMTg gene expression 0 0 1.18
RMTg isoform ratio 0 0 1.12
RMTg intron excision ratio 0 0 1.17
RMTg mRNA stability 0 0 1.4